Founded in 1983, Schulman IRB is the leading independent institutional review board dedicated to safeguarding the rights and welfare of clinical research participants.
We present the research communities of the U.S., Puerto Rico and Canada with a unique value proposition: Thorough, timely ethical reviews, conducted by a deeply experienced Board, backed by highly responsive customer service and custom-developed, Part 11 compliant technology tools. By combining these factors, we both improve human subject protection and address the operational needs of those we work with.
In addition to reviews of all phases of research across all therapeutic areas, we offer contract research organizations, investigators and institutions consulting services (through Provision Research Compliance Services and Falcon Consulting Group).
Three Decades of Partnership
To our clients – and study participants – we are more than a business venture. We’re a true partner, ensuring the highest levels of human subject protection by providing highly responsive customer service. When you work with Schulman IRB, you always have access to a dedicated point of contact who knows the details of your organization, your study and your submission. There’s never a question about who to call; if you have a question, just pick up the phone or send an email.
In addition, we recognize that the lifeblood of the clinical trial industry is time; unnecessary administrative delays can cost an organization millions. That’s why we strive to complete thorough, thoughtful ethical reviews swiftly; and we offer specialized review timelines for Phase I studies and qualifying minimal risk research. Schulman will never compromise on our core mission, but we will also never be an undue bottleneck.
Our IRB and staff boast an incomparable breadth and depth of expertise and experience in the clinical research industry. Members of our team have served in leadership positions at sponsors, CROs, sites and institutions, and have significant experience working in every research phase. Our IRB has reviewed studies in every therapeutic area and is well-versed in pharmaceutical, bio-pharmaceutical, device, behavioral and data collection research. From the simplest study to the most complex, we have the proven experience you need.
Clients rave about our Part 11 compliant suite of custom-deployed eTools. From electronic study and site submission to real-time tracking and customizable reporting dashboards, our highly intuitive technology suite dramatically reduces wasted time and duplicate effort. The best part? They’re designed and developed by our in-house team based on client feedback, and can be updated in as little as one day if an urgent request is received.